This is the multi-page printable view of this section. Click here to print.

Return to the regular view of this page.

Aggregation

Strategies and best practices for aggregating diverse pharmaceutical data sources into unified, analyzable, and reproducible datasets.

    Aggregation Strategies Come in Many Shapes and Sizes#

    Once data has been collected, it often exists in a variety of formats—PDFs, CSVs, Excel files, databases, and more. The challenge is to bring this disparate information together in a way that enables meaningful analysis, supports decision-making, and maintains data integrity.

    Aggregation is not a one-size-fits-all process. The optimal strategy depends on your goals, available resources, and the complexity of your data landscape. The focus should always be on fit-for-purpose approaches that optimize speed, cost, and quality.

    Key Considerations for Data Aggregation#

    • Conformance to a Common Data Model: Standardizing data into a unified structure is essential for downstream analytics, regulatory submissions, and reproducibility.
    • Data Cleaning and Transformation: Raw data often requires cleaning, normalization, and transformation to ensure consistency and usability.
    • Automation vs. Manual Integration: Automated pipelines can accelerate aggregation and reduce errors, but manual curation may be necessary for complex or legacy datasets.
    • Documentation and Traceability: Every step in the aggregation process should be well-documented to ensure transparency and reproducibility.

    Recipe-Based Approach#

    Our recommended strategy is to follow a recipe-based approach, which provides a structured, repeatable method for aggregating and transforming data. This approach emphasizes modularity, transparency, and adaptability—key principles for robust data management in pharmaceutical research and manufacturing.

    For a detailed discussion and practical examples, see the following paper: